Press releases
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Apr 2, 2007
Boston Scientific Corporation (NYSE: BSX) today announced that enrollment has begun in its MAPS™ clinical trial. The MAPS trial (Matrix And...
-
Mar 26, 2007BTK CHILL study demonstrates high rate of limb protection at one year
Boston Scientific Corporation (NYSE: BSX) today announced excellent one-year results from its Below-The-Knee (BTK) CHILL study,...
-
Mar 25, 2007
Boston Scientific Corporation (NYSE: BSX) today announced two-year results from the TAXUS V In-Stent Restenosis (ISR) trial,...
-
Mar 25, 2007Two-year review of TAXUS Stent safety data presented at ACC
Boston Scientific Corporation (NYSE: BSX) today announced two-year results from its ARRIVE 1 registry and the combined one-year...
-
Mar 24, 2007Results reaffirm strength of Boston Scientific's dual drug-eluting stent program
Boston Scientific Corporation (NYSE: BSX) today welcomed the results of the pivotal SPIRIT III clinical trial, which reaffirmed...
-
Mar 23, 2007
Boston Scientific Corporation (NYSE: BSX) today announced a program designed to improve patient compliance with physician-prescribed anti-platelet...
-
Mar 22, 2007Smallest Dual Chamber System offered in Japan provides enhanced therapies to patients at risk of sudden cardiac death
Boston Scientific Corporation (NYSE: BSX) today announced regulatory approval and market launch in Japan for its VITALITY™ DR implantable...
-
Mar 20, 2007Company to host analyst meeting and symposium on drug-eluting stents
Boston Scientific Corporation (NYSE: BSX) today announced the schedule of the Company's major events and press announcements at the annual...
-
Mar 13, 2007
Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the Lehman Brothers Health Care Conference, which is being held March 19...
-
Mar 12, 2007
Boston Scientific Corporation (NYSE: BSX) today announced that its Board of Directors has authorized management to explore an initial public...